DossierENTITY

Chiesi

Coverage of Chiesi in the Nexus archive.

Earliest in view: Apr 29 · 11:05 UTCMost recent: Apr 29 · 11:05 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSApr 29 · 11:05 UTCBLOOMBERG
Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
Chiesi has agreed to acquire KalVista Pharmaceuticals for $1.9 billion, a significant move in the pharmaceutical industry. The deal aims to expand Chiesi's portfolio in innovative therapies.